• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

简单快速地实时监测脂蛋白脂肪酶活性。

Simple and rapid real-time monitoring of LPL activity .

作者信息

Kluge Stefan, Boermel Lisa, Schubert Martin, Lorkowski Stefan

机构信息

Institute of Nutritional Sciences, Friedrich Schiller University Jena, Germany.

Competence Cluster for Nutrition and Cardiovascular Health (nutriCARD) Halle-Jena-Leipzig, Germany.

出版信息

MethodsX. 2020 Mar 17;7:100865. doi: 10.1016/j.mex.2020.100865. eCollection 2020.

DOI:10.1016/j.mex.2020.100865
PMID:32274337
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7132154/
Abstract

Since elevated plasma triglycerides are an independent risk factor for cardiovascular diseases, lipoprotein lipase (LPL) is an interesting target for drug development. However, investigation of LPL remains challenging, as most of the commercially available assays are limited to the determination of LPL activity. Thus, we focused on the evaluation of a simple real-time fluorescence assay for the measurement of LPL activity that can be combined with additional cell or molecular biological assays in the same cell sample. Our procedure allows for a more comprehensive characterization of potential regulatory compounds targeting the LPL system. The presented assay procedure provides several advantages over currently available commercial LPL activity assays:1.12-well cell culture plate design for the simultaneous investigation of up to three different compounds of interest (including all assay controls).2.24 h real-time acquisition of LPL activity for the identification of the optimal time point for further measurements.3.Measurement of LPL activity can be supplemented by additional cell or molecular biological assays in the same cell sample.

摘要

由于血浆甘油三酯升高是心血管疾病的独立危险因素,脂蛋白脂肪酶(LPL)是药物开发的一个有趣靶点。然而,对LPL的研究仍然具有挑战性,因为大多数市售检测方法仅限于测定LPL活性。因此,我们专注于评估一种简单的实时荧光检测方法来测量LPL活性,该方法可与同一细胞样本中的其他细胞或分子生物学检测方法相结合。我们的方法能够更全面地表征靶向LPL系统的潜在调节化合物。与目前可用的商业LPL活性检测方法相比,本检测方法具有以下几个优点:1.采用12孔细胞培养板设计,可同时研究多达三种不同的目标化合物(包括所有检测对照)。2.对LPL活性进行24小时实时采集,以确定进一步测量的最佳时间点。3.在同一细胞样本中,LPL活性的测量可通过额外的细胞或分子生物学检测进行补充。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1615/7132154/2b7d11bcac3e/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1615/7132154/b07fa20bfa2a/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1615/7132154/2b7d11bcac3e/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1615/7132154/b07fa20bfa2a/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1615/7132154/2b7d11bcac3e/gr1.jpg

相似文献

1
Simple and rapid real-time monitoring of LPL activity .简单快速地实时监测脂蛋白脂肪酶活性。
MethodsX. 2020 Mar 17;7:100865. doi: 10.1016/j.mex.2020.100865. eCollection 2020.
2
Ex vivo measurement of lipoprotein lipase-dependent very low density lipoprotein (VLDL)-triglyceride hydrolysis in human VLDL: an alternative to the postheparin assay of lipoprotein lipase activity?人极低密度脂蛋白(VLDL)中脂蛋白脂肪酶依赖性极低密度脂蛋白甘油三酯水解的体外测量:脂蛋白脂肪酶活性肝素后检测法的替代方法?
J Clin Endocrinol Metab. 2001 Feb;86(2):797-803. doi: 10.1210/jcem.86.2.7261.
3
Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 and angiopoietin-like protein 4 are associated with the increase of lipoprotein lipase activity in epicardial adipose tissue from diabetic patients.糖基磷脂酰肌醇锚定高密度脂蛋白结合蛋白 1 和血管生成素样蛋白 4 与糖尿病患者心外膜脂肪组织中脂蛋白脂肪酶活性的增加相关。
Atherosclerosis. 2019 Sep;288:51-59. doi: 10.1016/j.atherosclerosis.2019.06.915. Epub 2019 Jul 6.
4
Influence of lipoprotein lipase and hepatic lipase on the transformation of VLDL and HDL during lipolysis of VLDL.脂蛋白脂肪酶和肝脂肪酶对极低密度脂蛋白(VLDL)脂解过程中VLDL和高密度脂蛋白(HDL)转化的影响。
Atherosclerosis. 1995 Dec;118(2):193-212. doi: 10.1016/0021-9150(95)05606-8.
5
Growth hormone upregulates ANGPTL4 mRNA and suppresses lipoprotein lipase via fatty acids: Randomized experiments in human individuals.生长激素通过脂肪酸上调 ANGPTL4 mRNA 并抑制脂蛋白脂肪酶:人体随机实验。
Metabolism. 2020 Apr;105:154188. doi: 10.1016/j.metabol.2020.154188. Epub 2020 Feb 18.
6
Lipoprotein lipase liberates free fatty acids to inhibit HCV infection and prevent hepatic lipid accumulation.脂蛋白脂肪酶释放游离脂肪酸以抑制丙型肝炎病毒感染并防止肝脏脂质积累。
Cell Microbiol. 2017 Apr;19(4). doi: 10.1111/cmi.12673. Epub 2016 Nov 25.
7
[Pathologic decrease in lipoprotein lipase activity in relation to the development of hyperlipemias and their significance for coronary heart disease].[脂蛋白脂肪酶活性病理性降低与高脂血症发生发展的关系及其对冠心病的意义]
Wien Klin Wochenschr Suppl. 1986;167:1-16.
8
Inactivation of lipoprotein lipase in 3T3-L1 adipocytes by angiopoietin-like protein 4 requires that both proteins have reached the cell surface.血管生成素样蛋白 4 使 3T3-L1 脂肪细胞中的脂蛋白脂肪酶失活需要这两种蛋白都到达细胞表面。
Biochem Biophys Res Commun. 2013 Nov 29;441(4):941-6. doi: 10.1016/j.bbrc.2013.11.013. Epub 2013 Nov 9.
9
Lipoprotein lipase activity does not predict very low-density lipoprotein-triglyceride fatty acid oxidation during exercise.脂蛋白脂肪酶活性无法预测运动期间极低密度脂蛋白甘油三酯脂肪酸的氧化情况。
Scand J Med Sci Sports. 2017 May;27(5):474-481. doi: 10.1111/sms.12859. Epub 2017 Mar 19.
10
Impact of native VLDL on tissue factor pathway inhibitor in endothelial cells and interactions between TFPI and lipoprotein lipase.内源性极低密度脂蛋白对内皮细胞中组织因子途径抑制物的影响以及组织因子途径抑制物与脂蛋白脂肪酶之间的相互作用。
J Lab Clin Med. 2006 Apr;147(4):167-73. doi: 10.1016/j.lab.2005.11.010.

引用本文的文献

1
Omega-3 fatty acid regulation of lipoprotein lipase and FAT/CD36 and its impact on white adipose tissue lipid uptake.ω-3 脂肪酸对脂蛋白脂肪酶和 FAT/CD36 的调节及其对白色脂肪组织脂质摄取的影响。
Lipids Health Dis. 2024 Nov 20;23(1):386. doi: 10.1186/s12944-024-02376-7.
2
Comparative efficacy of pharmacological agents on reducing the risk of major adverse cardiovascular events in the hypertriglyceridemia population: a network meta-analysis.药物制剂对降低高甘油三酯血症人群主要不良心血管事件风险的比较疗效:一项网状Meta分析。
Diabetol Metab Syndr. 2021 Jan 29;13(1):15. doi: 10.1186/s13098-021-00626-7.

本文引用的文献

1
Severe hypertriglyceridaemia and pancreatitis in a patient with lipoprotein lipase deficiency based on mutations in lipoprotein lipase (LPL) and apolipoprotein A5 (APOA5) genes.一名脂蛋白脂肪酶缺乏症患者出现严重高甘油三酯血症和胰腺炎,基于脂蛋白脂肪酶(LPL)和载脂蛋白A5(APOA5)基因的突变。
BMJ Case Rep. 2019 Apr 3;12(4):e228199. doi: 10.1136/bcr-2018-228199.
2
Peroxisome proliferator-activated receptor gamma expression in peripheral blood mononuclear cells and angiopoietin-like protein 4 levels in obese children and adolescents.肥胖儿童和青少年外周血单个核细胞中过氧化物酶体增殖物激活受体γ的表达和血管生成素样蛋白 4 水平。
J Endocrinol Invest. 2018 Feb;41(2):241-247. doi: 10.1007/s40618-017-0730-y. Epub 2017 Jul 21.
3
Lipoprotein lipase activity and interactions studied in human plasma by isothermal titration calorimetry.
通过等温滴定量热法研究人血浆中的脂蛋白脂肪酶活性及相互作用。
J Lipid Res. 2017 Jan;58(1):279-288. doi: 10.1194/jlr.D071787. Epub 2016 Nov 14.
4
Triglyceride-Rich Lipoproteins and Remnants: Targets for Therapy?富含甘油三酯的脂蛋白及其残粒:治疗靶点?
Curr Cardiol Rep. 2016 Jul;18(7):67. doi: 10.1007/s11886-016-0745-6.
5
Orlistat response to missense mutations in lipoprotein lipase.奥利司他对脂蛋白脂肪酶错义突变的反应。
Biotechnol Appl Biochem. 2017 Jul;64(4):464-470. doi: 10.1002/bab.1500. Epub 2016 Sep 28.
6
Surprises From Genetic Analyses of Lipid Risk Factors for Atherosclerosis.动脉粥样硬化脂质风险因素遗传分析中的意外发现。
Circ Res. 2016 Feb 19;118(4):579-85. doi: 10.1161/CIRCRESAHA.115.306398.
7
Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights From Epidemiology, Genetics, and Biology.富含甘油三酯的脂蛋白与动脉粥样硬化性心血管疾病:来自流行病学、遗传学和生物学的新见解。
Circ Res. 2016 Feb 19;118(4):547-63. doi: 10.1161/CIRCRESAHA.115.306249.
8
New Therapeutic Approaches to the Treatment of Dyslipidemia.血脂异常治疗的新方法
Cell Metab. 2016 Mar 8;23(3):405-12. doi: 10.1016/j.cmet.2016.01.005. Epub 2016 Feb 4.
9
Post-heparin LPL activity measurement using VLDL as a substrate: a new robust method for routine assessment of plasma triglyceride lipolysis defects.以极低密度脂蛋白(VLDL)为底物的肝素后脂蛋白脂肪酶(LPL)活性测定:一种用于常规评估血浆甘油三酯脂解缺陷的新的可靠方法。
PLoS One. 2014 May 2;9(5):e96482. doi: 10.1371/journal.pone.0096482. eCollection 2014.
10
Activation of receptors δ (PPARδ) by agonist (GW0742) may enhance lipid metabolism in heart both in vivo and in vitro.激动剂(GW0742)激活受体 δ(PPARδ)可增强体内和体外心脏的脂质代谢。
Horm Metab Res. 2013 Nov;45(12):880-6. doi: 10.1055/s-0033-1348317. Epub 2013 Jun 26.